Dr. Adam Robinson-Miller has more than a decade of experience in the pharmaceutical and OTC environments, with particular focus on formulation design, DoE and QbD strategies for innovative drug products. More recently, Adam has become one of our established SME’s in the design of human ADME studies, supporting biotechs and large pharma with their ADME strategy.

Over the course of his career, Adam has worked across multiple drug modalities and across the globe to support new medicines to market. Adam also was a guest lecturer at Hull University for the Masters in Pharmacology and Drug Development.

Adam holds an MChem in Chemistry with Medicinal Chemistry from Newcastle University, and a PhD in Chemistry from Northumbria University.